Romanians bought drugs worth EUR 755 million in distribution price in the last quarter of 2014, up 11.8% year-on-year.

The increase in non-prescription drugs and in products for chronical diseases triggered this growth, according to the Pharma & Hospital Report presented by market analysis company Cegedim, reports local Economica.net.

The prescription drugs amounted to EUR 531 million, up 9.6% over the same period in 2013, whereas the non-prescription drugs reached EUR 133 million, up 19.5% year-on-year.

The hospital segment amounted to EUR 90 million, up 13.8% over 2013.

French pharma group Sanofi ranked first on the Romanian market, with sales worth EUR 192 million, followed by Swiss group Hoffmann La Roche, with EUR 181 million sales.

editor@romania-insider.com